Bellecapital’s Hologic HOLX Stock Holding History

Bellecapital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,167	Closed	-$459K	–	187
2021 Q1	$459K	Buy	6,167 +359	+6%	+$27.3K	0.14%	117
2020 Q4	$423K	Buy	+5,808	New	+$410K	0.14%	124

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bellecapital's HOLX Position: Q2 2021 in Review

Bellecapital sold out of Hologic (HOLX) in Q2 2021, closing a stake of 6,167 shares — an estimated $459K sold.

Bellecapital first reported a position in HOLX in Q4 2020 and held it in 2 quarters. The position peaked at $459K in Q1 2021. 624 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

Bellecapital reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
Bellecapital sold 6,167 Hologic shares in Q2 2021, an estimated $459K.
Bellecapital first reported a position in Hologic in Q4 2020 and held it in 2 quarters.
Bellecapital's Hologic position peaked at $459K in Q1 2021.
624 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Bellecapital's 13F filing for Q2 2021, filed 28 Jul 2021.